Correlation Between OBI Pharma and Xxentria Technology

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both OBI Pharma and Xxentria Technology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining OBI Pharma and Xxentria Technology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between OBI Pharma and Xxentria Technology Materials, you can compare the effects of market volatilities on OBI Pharma and Xxentria Technology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in OBI Pharma with a short position of Xxentria Technology. Check out your portfolio center. Please also check ongoing floating volatility patterns of OBI Pharma and Xxentria Technology.

Diversification Opportunities for OBI Pharma and Xxentria Technology

0.86
  Correlation Coefficient

Very poor diversification

The 3 months correlation between OBI and Xxentria is 0.86. Overlapping area represents the amount of risk that can be diversified away by holding OBI Pharma and Xxentria Technology Materials in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Xxentria Technology and OBI Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on OBI Pharma are associated (or correlated) with Xxentria Technology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Xxentria Technology has no effect on the direction of OBI Pharma i.e., OBI Pharma and Xxentria Technology go up and down completely randomly.

Pair Corralation between OBI Pharma and Xxentria Technology

Assuming the 90 days trading horizon OBI Pharma is expected to under-perform the Xxentria Technology. In addition to that, OBI Pharma is 1.26 times more volatile than Xxentria Technology Materials. It trades about -0.16 of its total potential returns per unit of risk. Xxentria Technology Materials is currently generating about -0.18 per unit of volatility. If you would invest  5,540  in Xxentria Technology Materials on October 8, 2024 and sell it today you would lose (230.00) from holding Xxentria Technology Materials or give up 4.15% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthStrong
Accuracy100.0%
ValuesDaily Returns

OBI Pharma  vs.  Xxentria Technology Materials

 Performance 
       Timeline  
OBI Pharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days OBI Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of abnormal performance in the last few months, the Stock's basic indicators remain fairly stable which may send shares a bit higher in February 2025. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.
Xxentria Technology 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Xxentria Technology Materials has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest abnormal performance, the Stock's basic indicators remain stable and the latest fuss on Wall Street may also be a sign of long-term gains for the venture sophisticated investors.

OBI Pharma and Xxentria Technology Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with OBI Pharma and Xxentria Technology

The main advantage of trading using opposite OBI Pharma and Xxentria Technology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if OBI Pharma position performs unexpectedly, Xxentria Technology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Xxentria Technology will offset losses from the drop in Xxentria Technology's long position.
The idea behind OBI Pharma and Xxentria Technology Materials pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.

Other Complementary Tools

Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Share Portfolio
Track or share privately all of your investments from the convenience of any device
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like